#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	7442	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2885	620.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1779	1779	C	895	C,T,G,A	809,1,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	7442	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2885	620.6	0	HET	.	.	.	C207T,G,A	.	207	207	C	802	802	C	666	C,T,G,A	463,130,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	12874	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4363	715.9	0	.	n	.	0	T695C	SNP	695	695	T	1475	1475	C	925	C,A,T,G	835,3,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	12874	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4363	715.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2418	2418	G	895	G,A,T	842,2,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	12874	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4363	715.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2751	2751	C	932	C,A,G	857,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	12874	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4363	715.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2825	2825	A	911	A,T	841,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	12874	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4363	715.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3377	3377	C	868	C,T	813,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	880	folP	855	855	100.0	folP.l6.c17.ctg.1	2054	102.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1328	1330	AGC	127;126;125	A,C;G;C	114,1;117;116	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1948	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4122	114.9	1	SNP	p	S91F	1	.	.	271	273	TTC	953	955	TTC	128;129;128	T,C;T;C,T,G	110,1;111;111,3,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1948	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4122	114.9	1	SNP	p	G95N	0	.	.	283	285	GGC	965	967	GGC	139;139;139	G,T;G,C;C	120,1;119,1;116	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1948	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4122	114.9	1	SNP	p	D95G	1	.	.	283	285	GGC	965	967	GGC	139;139;139	G,T;G,C;C	120,1;119,1;116	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	283	654	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	2293	69.8	1	SNP	p	G45D	0	.	.	133	135	GGC	1220	1222	CCG	187;187;187	C;C;G	167;167;168	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	438	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1589	67.2	0	.	n	.	0	A197.	DEL	197	197	A	873	873	A	149	A	141	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1674	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3548	114.7	1	SNP	p	D86N	0	.	.	256	258	GAC	882	884	GAC	97;97;99	G,A;A,G;C	69,1;60,1;75	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1674	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3548	114.7	1	SNP	p	R87W	0	.	.	259	261	CGT	885	887	CGT	100;100;102	C,A;G,C;T,G	87,1;73,1;77,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1674	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3548	114.7	1	SNP	p	S87R	1	.	.	259	261	CGT	885	887	CGT	100;100;102	C,A;G,C;T,G	87,1;73,1;77,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1674	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3548	114.7	1	SNP	p	R87I	0	.	.	259	261	CGT	885	887	CGT	100;100;102	C,A;G,C;T,G	87,1;73,1;77,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1674	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3548	114.7	1	SNP	p	S88P	0	.	.	262	264	TCC	888	890	TCC	102;102;102	T;C,T;C	86;86,1;92	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1772	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3325	130.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1901	1903	GGC	135;137;140	G;G;C	119;114;115	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.002	penA.34.002	1	1	27	1586	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2653	143.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1500	1502	GCC	202;203;202	G;C;C,A	180;183;181,1	penA.34.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1586	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2653	143.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1503	1505	ATG	203;203;201	A;T,G;G,A	182;181,1;178,1	penA.34.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1586	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2653	143.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1515	1517	ACC	196;196;194	A;C;C,A	175;177;175,1	penA.34.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1586	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2653	143.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1515	1517	ACC	196;196;194	A;C;C,A	175;177;175,1	penA.34.002:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1586	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2653	143.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2016	2018	ACC	152;152;145	A;C;C,G	135;132;132,1	penA.34.002:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1586	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2653	143.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2070	2072	GCG	146;146;146	G;C;G	125;116;128	penA.34.002:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1586	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2653	143.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2070	2072	GCG	146;146;146	G;C;G	125;116;128	penA.34.002:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1586	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2653	143.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2193	2195	GGT	124;124;122	G,T,A;G,T,C;T,G	117,1,1;108,10,1;116,1	penA.34.002:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1586	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2653	143.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2202	2204	AGC	106;106;106	A;G;C,G	65;83;68,5	penA.34.002:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1586	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2653	143.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2220	2222	CCG	98;97;97	C;C,A;G,C	82;79,1;80,5	penA.34.002:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	2014	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3639	133.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1798	1800	CCG	165;166;166	C,G,T;C,A;G,C	125,3,1;143,1;113,7	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	750	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2624	70.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	971	971	C	71	C,G	54,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1080	porB1b	1038	1038	99.62	porB1b.l15.c4.ctg.1	2225	117.1	0	.	p	.	0	G48R	NONSYN	142	144	GGA	597	599	AGA	157;157;159	A,C;G,A;A	150,1;149,1;153	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1080	porB1b	1038	1038	99.62	porB1b.l15.c4.ctg.1	2225	117.1	0	.	p	.	0	Y211_A212insD	INS	631	631	T	1086	1086	T	191	T,A	185,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1080	porB1b	1038	1038	99.62	porB1b.l15.c4.ctg.1	2225	117.1	1	SNP	p	G120K	1	.	.	358	360	AAG	813	815	AAG	141;141;138	A,C;A,C;G,A	129,3;131,1;126,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1080	porB1b	1038	1038	99.62	porB1b.l15.c4.ctg.1	2225	117.1	1	SNP	p	N121D	0	.	.	361	363	AAC	816	818	AAC	140;140;135	A;A,G,C;C,A,T	127;124,2,1;118,4,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1080	porB1b	1038	1038	99.62	porB1b.l15.c4.ctg.1	2225	117.1	1	SNP	p	A121N	1	.	.	361	363	AAC	816	818	AAC	140;140;135	A;A,G,C;C,A,T	127;124,2,1;118,4,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3956	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5379	179.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	534	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1637	80.3	1	SNP	p	V57M	1	.	.	169	171	ATG	846	848	ATG	154;153;154	A;T;G,T	144;145;145,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
